Neurogene is a biotechnology company which accelerates the development of genetic medicines to people with devastating neurological diseases. The Company's programs use AAV-based gene therapy technology to deliver a normal gene to patients with a dysfunctional gene. Neurogene also invests in novel technologies to develop treatments for diseases not well served by gene therapy.
|HQ||New York, US||Map|
|Employees (est.) (Sept 2020)||39||(+3%)|
Neurogene total Funding
Neurogene latest funding size
Time since last funding
|2 years ago|
|Redmile Group, EcoR1 Capital, Cormorant Asset Management, Samsara BioCapital|
Neurogene has 6 Twitter Followers. The number of followers has increased 20% quarter over quarter
When was Neurogene founded?
Neurogene was founded in 2018.
Who are Neurogene key executives?
Neurogene's key executives are Rachel McMinn, Effie Albanis and Christine Mikail.
How many employees does Neurogene have?
Neurogene has 39 employees.
Who are Neurogene competitors?
Competitors of Neurogene include ProQR Therapeutics, Fulgent Genetics and Asklepios BioPharmaceutical.
Where is Neurogene headquarters?
Neurogene headquarters is located at 535 W 24th St 5th floor, New York.
Where are Neurogene offices?
Neurogene has an office in New York.
How many offices does Neurogene have?
Neurogene has 1 office.
Receive alerts for 300+ data fields across thousands of companies